Maersk Enters Partnership With Novo Nordisk For Transporting Pharmaceuticals On A Global Level
A.P. Moller– Maersk revealed the finalizing of a logistics arrangement with Novo Nordisk from 2021. The three-year arrangement on chilly chain logistics covers transport consisting of sea solutions and also inland logistics.
“We are pleased to be picked as one of Novo Nordisk ´ s major logistic firms. Transporting drugs on a worldwide degree is a requiring job with different intricacies that call for versatile and also durable supply chains along with electronic and also green remedies.
This accomplishment showcases the fast change of A.P. Moller– Maersk as a modern-day end-to-end logistics firm with totally regulated properties,” claimed Vincent Clerc, Executive Vice President, and also Chief Executive Officer Ocean and alsoLogistics A.P. Moller– Maersk.
One of the biggest pharmaceutical firms worldwide, Novo Nordisk has actually picked Maersk ´ s ECO Delivery to minimize the carbon impact in transport. The campaign makes use of lasting biofuel to power picked Maersk- vessels and also assists Novo Nordisk to make progression in the direction of its enthusiastic sustainability objectives.
The international arrangement will certainly go into result since first April 2021.
Our aspiration of accomplishing no ecological effect is a keystone of our goal to be a really lasting organization. We take into consideration A.P. Moller– Maersk to be the best international circulation companion to protect the stable, eco-friendly shipment of our high-value deliveries and also we expect the partnership.
Rune Sylow
Corporate Vice President, Strategic Sourcing Novo Nordisk
Reference: maersk.com